Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants
Adequate Breast Milk for Improved Health of Very Low Birth Weight Preterm Infants
3 other identifiers
interventional
180
1 country
1
Brief Summary
Compelling evidence exists that breast milk helps protect very premature infants from prematurity-specific morbidities. Unfortunately, mothers of premature infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and decreased breast milk production. Several studies have linked earlier initiation of breast milk expression following delivery with a greater milk production. However, none conclusively determined the optimal timing of breast milk expression. As a result these mothers continue to struggle with inadequate breast milk production. This study will follow 180 mothers of premature infants for 6 weeks following delivery to test Earlier initiation of breast milk expression following delivery is associated with (1) an earlier lactogenesis stage II, (2) greater volume of breast milk production during the first 6 weeks, (3) improved short-term infant health outcomes and (4) women who deliver at an earlier gestation will have decreased milk production and a later lactogenesis stage II. Following stratification according to the gestational age of the infant (23-27 weeks vs. 28-32 weeks), eligible women will be randomly assigned to one of three groups and instructed to start mechanically expressing their r breasts, either in the first hour, 1-3 hours or 3-6 hours following delivery. The timing of lactogenesis stage II will be documented, and the volume of breast milk produced will continue to be measured for the first 6 weeks following delivery and at discharge. Infant nutritional outcomes will be measured throughout the 6-week study. The impact of the differences in timing of initiation of milk expression following delivery on timing of lactogenesis stage II, milk volume, short term nutritional outcomes, amount of breast milk feedings at discharge, and impact of gestational age on milk volume and lactogenesis stage II will be determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2013
CompletedFirst Posted
Study publicly available on registry
July 3, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedResults Posted
Study results publicly available
August 24, 2023
CompletedAugust 24, 2023
July 1, 2023
3.8 years
June 28, 2013
April 11, 2023
July 31, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Pumped Milk Volume Day 1
Volume of pumped milk on day 1 postpartum
Day 1 postpartum
Pumped Milk Volume on Day 2
Volume of breast milk pumped on day 2 postpartum
Day 2 postpartum
Pumped Milk Volume Day 3
Volume of milk pumped on day 3 postpartum
Day 3 postpartum
Pumped Milk Volume Day 4
Volume of pumped milk on Day 4 postpartum
Day 4 postpartum
Pumped Milk Volume on Day 5
Volume of pumped milk on Day 5 postpartum
Day 5 postpartum
Pumped Milk Volume Day 6
Volume of pumped milk on Day 6 postpartum
Day 6 postpartum
Pumped Milk Volume on Day 7
Volume of milk pumped on day 7 postpartum
Day 7 postpartum
Pumped Milk Volume at Day 14
Volume of pumped milk on day 14 postpartum
Day 14 postpartum
Pumped Milk Volume Day 21
Volume of milk pumped on day 21 postpartum
Day 21 postpartum
Pumped Milk Volume Day 28
Volume of milk pumped on day 28 postpartum
Day 28 postpartum
Pumped Milk Volume on Day 35
Volume of milk pumped on day 35 postpartum
Day 35 postpartum
Pumped Milk Volume on Day 42
Volume of milk pumped on day 42 postpartum
Day 42 postpartum
Secondary Outcomes (9)
Hours From Birth to Onset of Lactogenesis Stage 2
Hours from birth to onset of lactogenesis stage 2
Days Lactated
birth to approximately 3 months
Percentage of Feeds Consisting of Mother's Own Milk Week 1
Day 1 to 7
Percentage of Feeds Consisting of Mother's Own Milk Week 2 Consumed by Infants
Day 7-14
Percentage of Feeds Consisting of Mother's Own Milk Week 3
Day 14-21
- +4 more secondary outcomes
Study Arms (3)
Early initiation
EXPERIMENTALInitiation of breast milk expression \<1 hour following delivery.
Intermediate expression
EXPERIMENTALInitiation of milk expression 1-\<3 hours following delivery.
Late initiation
OTHERInitiation of milk expression \>3-6 hours following delivery.
Interventions
Initiation of breast milk expression \<1 hour following delivery.
Initiation of milk expression 1-\<3 hours following delivery.
Initiation of milk expression \>3-6 hours following delivery.
Eligibility Criteria
You may qualify if:
- \) at least 18 years of age,
- \) English or Spanish-speaking,
- \) stated intent to breastfeed,
- \) anticipating the birth of a very low birth weight infant (≤1500 grams) between 23-32 weeks gestation.
You may not qualify if:
- \) known illicit maternal drug use,
- \) history of breast reduction or augmentation,
- \) positive HIV status,
- \) mother not transported to recovery by 45 minutes following delivery or
- \) infant not expected to live over 2 weeks following delivery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida Shands
Gainesville, Florida, 32605, United States
Related Publications (1)
Parker LA, Sullivan S, Cacho N, Krueger C, Mueller M. Effect of Postpartum Depo Medroxyprogesterone Acetate on Lactation in Mothers of Very Low-Birth-Weight Infants. Breastfeed Med. 2021 Oct;16(10):835-842. doi: 10.1089/bfm.2020.0336. Epub 2021 Apr 28.
PMID: 33913765DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Leslie Parker
- Organization
- University of Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Leslie A Parker, PhD
University of Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2013
First Posted
July 3, 2013
Study Start
November 1, 2013
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
August 24, 2023
Results First Posted
August 24, 2023
Record last verified: 2023-07